Cargando…
Evaluation of Immunogenicity by Pseudovirus Neutralization Assays for SARS‐CoV‐2 Variants after Primary and Booster Immunization
OBJECTIVES: To determine the status of immune responses after primary and booster immunization for SARS-CoV-2 variants and evaluate the differences in disease resistance based upon titers of neutralizing antibodies (NAbs) against the variants. METHODS: Participants aged 18–59 years received 2 doses...
Autores principales: | Xie, Hui, Wen, Xiaojing, Li, Juan, Chen, Weixin, Chen, Meng, Zhang, Lichi, Lv, Min, Zhou, Shanshan, Bai, Shuang, Zhao, Wei, Wang, Jian, Wu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809669/ https://www.ncbi.nlm.nih.gov/pubmed/35123028 http://dx.doi.org/10.1016/j.ijid.2022.01.068 |
Ejemplares similares
-
Developing Pseudovirus-Based Neutralization Assay against Omicron-Included SARS-CoV-2 Variants
por: Sun, Hancong, et al.
Publicado: (2022) -
A Simplified SARS-CoV-2 Pseudovirus Neutralization Assay
por: Donofrio, Gaetano, et al.
Publicado: (2021) -
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
por: Nie, Jianhui, et al.
Publicado: (2020) -
Combining MOE Bioinformatics Analysis and In Vitro Pseudovirus Neutralization Assays to Predict the Neutralizing Ability of CV30 Monoclonal Antibody on SARS-CoV-2 Variants
por: Zhu, Yajuan, et al.
Publicado: (2023) -
A high-throughput SARS-CoV-2 pseudovirus multiplex neutralization assay
por: Sievers, Benjamin Louis, et al.
Publicado: (2022)